A Phase II Trial of Fludarabine/Melphalan 100 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Patients With Lymphoma. [electronic resource]
Producer: 20160909Description: 655-63 p. digitalISSN:- 2152-2669
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Female
- Graft Survival
- Graft vs Host Disease -- etiology
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Lymphoma -- diagnosis
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Prognosis
- Transplantation Conditioning
- Transplantation, Homologous
- Treatment Outcome
- Vidarabine -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.